top of page

PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G

Product details

Registration number: SIN15308P

Classification: Prescription Only

Active ingredients:

  • Piperacillin sodium sterile 4.170 g corresponding to Piperacillin
  • Tazobactam sodium sterile 536.6 mg corresponding to Tazobactam

Strength:

  • 4.0 g
  • 0.5g

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

ATC code: J01CR05

HSA approval date: 31 July 2017

Manufacturer(s):

  • Labesfal - Laboratorios Almiro S.A. (Fresenius Kabi Group)
  • Fresenius Kabi iPSUM Srl (Villadose plant) (Intermediate)

Manufacturing country/countries: ITALY; PORTUGAL

What are the HSA registration number and classification for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15308P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Piperacillin sodium sterile 4.170 g corresponding to Piperacillin
  • Tazobactam sodium sterile 536.6 mg corresponding to Tazobactam

Strength:

  • 4.0 g
  • 0.5g

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?

According to the HSA dataset updated 7 August 2026:

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Labesfal - Laboratorios Almiro S.A. (Fresenius Kabi Group)
  • Fresenius Kabi iPSUM Srl (Villadose plant) (Intermediate)

Manufacturing country/countries: ITALY; PORTUGAL

Source for this answer

Where can I look up PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15308P or the exact product name PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G. The general register link does not preselect this product.

Source for this answer

What are the source dates for this PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15308P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page